chemotherapy

You have access
ALK Inhibitor and Chemotherapy Combinations in Models of ALK-Translocated NSCLC
MILLA E.K. LUUKKAINEN and JUSSI P. KOIVUNEN

Anticancer Research July 2024, 44 (7) 2805-2813; DOI: https://doi.org/10.21873/anticanres.17092
You have access
A Retrospective Analysis of Systemic Oncologic Treatment in Older Patients With Advanced Soft-tissue Sarcoma
JASMIINI LEMMA, JASMIN LILJESTRÖM, MIKA SAMPO, RIIKKA NEVALA, CARL BLOMQVIST, MOHAMED ELMEGIRI and SARI JÄÄMAA

Anticancer Research July 2024, 44 (7) 3067-3075; DOI: https://doi.org/10.21873/anticanres.17120
You have access
A Comparative Analysis of ARX and ANFIS Models for Tumor Growth Prediction Under Single and Multi-agent Chemotherapy
SOTIRIOS G. LILIOPOULOS, GEORGE S. STAVRAKAKIS and KONSTANTINOS S. DIMAS

Anticancer Research June 2024, 44 (6) 2425-2436; DOI: https://doi.org/10.21873/anticanres.17049
You have access
Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer
SATOSHI ANO, NORIHIRO KIKUCHI, SHINICHIRO OKAUCHI, TAKESHI NUMATA, RYOTA NAKAMURA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, TOMOHIRO TAMURA, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, TAKAYUKI KABURAGI, TAKEO ENDO, HIROAKI SATOH and NOBUYUKI HIZAWA

Anticancer Research June 2024, 44 (6) 2725-2730; DOI: https://doi.org/10.21873/anticanres.17080
Open Access
Adenoid Cystic Carcinoma, Clinical Presentation, Current Treatment and Approaches Towards Novel Therapies
MARK ZUPANCIC, ANDERS NÄSMAN, SIGNE FRIESLAND and TINA DALIANIS

Anticancer Research April 2024, 44 (4) 1325-1334; DOI: https://doi.org/10.21873/anticanres.16929
You have access
Combined Neutrophil-to-Lymphocyte Ratio Score Is Associated With Chemotherapeutic Response and Predicts Prognosis in Patients With Advanced Pancreatic Cancer
HIROHISA OKABE, TOSHIRO MASUDA, MASAHIRO TOMITA, ASUKA ONO, DAISUKE OGAWA, DAISUKE KURODA, HIDEYUKI KUROKI, MASAHIKO HIROTA, TAIZO HIBI, HIDEO BABA and HIROKI SUGITA

Anticancer Research April 2024, 44 (4) 1575-1582; DOI: https://doi.org/10.21873/anticanres.16955
You have access
Effectiveness of Combination Chemotherapy With Docetaxel, Nedaplatin, and 5-Fluorouracil for Advanced and Recurrent Esophageal Cancer
MAKOTO SOHDA, KEIGO HARA, KENGO KURIYAMA, KOUHEI TATENO, SHINTARO UCHIDA, TAKAYOSHI WATANABE, YUTA SHIBASAKI, HIDEYUKI SAITO, NOBUHIRO NAKAZAWA, AKIHIKO SANO, MAKOTO SAKAI, TAKEHIKO YOKOBORI, HIROOMI OGAWA, KEN SHIRABE and HIROSHI SAEKI

Anticancer Research March 2024, 44 (3) 1309-1315; DOI: https://doi.org/10.21873/anticanres.16926
You have access
BRD4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell Lines
CLEMENS LANG, SANDRA STICKLER, BARBARA RATH, MARYANA TEUFELSBAUER, LUKAS WEIGL, MARTIN HOHENEGGER and GERHARD HAMILTON

Anticancer Research March 2024, 44 (3) 971-980; DOI: https://doi.org/10.21873/anticanres.16892
You have access
Post-traumatic Stress and Depressive Symptoms in Women With Ovarian Cancer 3-6 Months After Diagnosis
CLAUDIA CARMASSI, VIRGINIA PEDRINELLI, SARA FANTASIA, DEBORA ANDREOLI, FEDERICO GIOVANNONI, ENRICO MASSIMETTI, STEFANIA COSIO, LILIANA DELL’OSSO and ANGIOLO GADDUCCI

Anticancer Research February 2024, 44 (2) 829-838; DOI: https://doi.org/10.21873/anticanres.16875
Open Access
Opioid Use in Patients With Cervical Cancer at a Tertiary Academic Medical Center
MADISON NICHOLS, ANAM KESARIA, HORACE J. SPENCER, HEATHER R. WILLIAMS, SANTANU SAMANTA and GARY D. LEWIS

Anticancer Research January 2024, 44 (1) 151-155; DOI: https://doi.org/10.21873/anticanres.16797

Main menu

User menu

Search

chemotherapy

Pages